Birdwatch Note
2023-05-03 23:05:45 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Ivermectin is approved for human use to treat infections caused by some parasitic worms and head lice and skin conditions like rosacea. Ivermectin has no efficacy to treat or prevent COVID-19 based on results from randomized controlled trials https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362 https://jamanetwork.com/journals/jama/fullarticle/2777389 https://www.nejm.org/doi/full/10.1056/NEJMoa2115869 https://www.nejm.org/doi/full/10.1056/NEJMoa2201662
Written by 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1653865544423026689
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1653898669806977027
- noteId - 1653898669806977027
- participantId -
- noteAuthorParticipantId - 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31 Participant Details
- createdAtMillis - 1683155145490
- tweetId - 1653865544423026689
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Ivermectin is approved for human use to treat infections caused by some parasitic worms and head lice and skin conditions like rosacea. Ivermectin has no efficacy to treat or prevent COVID-19 based on results from randomized controlled trials https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362 https://jamanetwork.com/journals/jama/fullarticle/2777389 https://www.nejm.org/doi/full/10.1056/NEJMoa2115869 https://www.nejm.org/doi/full/10.1056/NEJMoa2201662
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-05-03 23:05:45 UTC (1683155145490) |
1969-12-31 23:59:59 UTC (-1) |
2023-05-06 02:42:24 UTC (1683340944665) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-05-05 15:58:24 -0500 | Rating Details | |
| 2023-05-05 13:30:55 -0500 | Rating Details | |
| 2023-05-05 13:20:00 -0500 | Rating Details | |
| 2023-05-05 11:37:54 -0500 | Rating Details | |
| 2023-05-05 09:06:58 -0500 | Rating Details | |
| 2023-05-05 07:32:27 -0500 | Rating Details | |
| 2023-05-04 21:45:40 -0500 | Rating Details | |
| 2023-05-04 20:40:07 -0500 | Rating Details | |
| 2023-05-04 20:34:18 -0500 | Rating Details | |
| 2023-05-04 20:26:32 -0500 | Rating Details | |
| 2023-05-04 19:33:44 -0500 | Rating Details | |
| 2023-05-04 18:57:47 -0500 | Rating Details | |
| 2023-05-04 18:46:58 -0500 | Rating Details | |
| 2023-05-04 18:46:22 -0500 | Rating Details | |
| 2023-05-04 18:26:55 -0500 | Rating Details | |
| 2023-05-04 18:07:46 -0500 | Rating Details | |
| 2023-05-04 17:48:06 -0500 | Rating Details | |
| 2023-05-04 15:12:33 -0500 | Rating Details | |
| 2023-05-04 13:22:10 -0500 | Rating Details | |
| 2023-05-04 11:51:37 -0500 | Rating Details | |
| 2023-05-04 11:35:14 -0500 | Rating Details | |
| 2023-05-04 11:16:58 -0500 | Rating Details | |
| 2023-05-04 11:00:26 -0500 | Rating Details | |
| 2023-05-04 10:33:23 -0500 | Rating Details | |
| 2023-05-04 10:30:02 -0500 | Rating Details | |
| 2023-05-04 09:48:21 -0500 | Rating Details | |
| 2023-05-04 09:42:11 -0500 | Rating Details | |
| 2023-05-04 08:52:58 -0500 | Rating Details | |
| 2023-05-04 08:49:52 -0500 | Rating Details | |
| 2023-05-04 08:39:18 -0500 | Rating Details | |
| 2023-05-04 08:17:14 -0500 | Rating Details | |
| 2023-05-04 08:11:29 -0500 | Rating Details | |
| 2023-05-04 07:54:02 -0500 | Rating Details | |
| 2023-05-04 07:52:54 -0500 | Rating Details | |
| 2023-05-04 07:50:59 -0500 | Rating Details | |
| 2023-05-04 07:41:05 -0500 | Rating Details | |
| 2023-05-04 07:40:22 -0500 | Rating Details | |
| 2023-05-04 07:37:29 -0500 | Rating Details | |
| 2023-05-04 07:30:56 -0500 | Rating Details | |
| 2023-05-04 07:30:21 -0500 | Rating Details | |
| 2023-05-04 07:25:58 -0500 | Rating Details | |
| 2023-05-04 07:24:57 -0500 | Rating Details | |
| 2023-05-04 07:24:15 -0500 | Rating Details | |
| 2023-05-04 07:24:08 -0500 | Rating Details | |
| 2023-05-04 07:11:59 -0500 | Rating Details | |
| 2023-05-04 07:00:49 -0500 | Rating Details | |
| 2023-05-04 07:00:37 -0500 | Rating Details | |
| 2023-05-04 06:53:06 -0500 | Rating Details | |
| 2023-05-04 06:51:27 -0500 | Rating Details | |
| 2023-05-04 06:32:54 -0500 | Rating Details | |
| 2023-05-04 06:23:19 -0500 | Rating Details | |
| 2023-05-04 05:50:14 -0500 | Rating Details | |
| 2023-05-04 05:37:04 -0500 | Rating Details | |
| 2023-05-04 05:16:03 -0500 | Rating Details | |
| 2023-05-04 02:51:54 -0500 | Rating Details | |
| 2023-05-04 01:26:33 -0500 | Rating Details | |
| 2023-05-04 00:19:42 -0500 | Rating Details | |
| 2023-05-04 00:08:19 -0500 | Rating Details | |
| 2023-05-03 22:43:41 -0500 | Rating Details | |
| 2023-05-03 22:41:37 -0500 | Rating Details | |
| 2023-05-03 22:39:07 -0500 | Rating Details | |
| 2023-05-03 22:11:12 -0500 | Rating Details | |
| 2023-05-03 22:06:27 -0500 | Rating Details | |
| 2023-05-03 21:56:48 -0500 | Rating Details | |
| 2023-05-03 21:40:53 -0500 | Rating Details | |
| 2023-05-03 21:21:48 -0500 | Rating Details | |
| 2023-05-03 21:09:06 -0500 | Rating Details | |
| 2023-05-03 20:50:34 -0500 | Rating Details | |
| 2023-05-03 20:49:35 -0500 | Rating Details | |
| 2023-05-03 20:44:18 -0500 | Rating Details | |
| 2023-05-03 20:32:53 -0500 | Rating Details | |
| 2023-05-03 20:31:41 -0500 | Rating Details | |
| 2023-05-03 20:14:23 -0500 | Rating Details | |
| 2023-05-03 20:06:05 -0500 | Rating Details | |
| 2023-05-03 19:57:47 -0500 | Rating Details | |
| 2023-05-03 19:52:32 -0500 | Rating Details | |
| 2023-05-03 19:49:26 -0500 | Rating Details | |
| 2023-05-03 19:11:03 -0500 | Rating Details | |
| 2023-05-03 19:02:52 -0500 | Rating Details | |
| 2023-05-03 18:57:23 -0500 | Rating Details | |
| 2023-05-03 18:44:58 -0500 | Rating Details | |
| 2023-05-03 18:23:35 -0500 | Rating Details | |
| 2023-05-06 15:50:40 -0500 | Rating Details | |
| 2023-05-08 20:45:50 -0500 | Rating Details | |
| 2023-05-04 05:50:14 -0500 | Rating Details | |
| 2023-05-03 21:56:48 -0500 | Rating Details | |
| 2023-05-04 08:52:58 -0500 | Rating Details | |
| 2023-05-05 13:30:55 -0500 | Rating Details | |
| 2023-05-03 21:09:06 -0500 | Rating Details | |
| 2023-05-04 11:35:14 -0500 | Rating Details | |
| 2023-05-04 19:33:44 -0500 | Rating Details | |
| 2023-05-05 07:32:27 -0500 | Rating Details | |
| 2023-05-04 18:46:22 -0500 | Rating Details | |
| 2023-05-04 06:32:54 -0500 | Rating Details | |
| 2023-05-04 10:33:23 -0500 | Rating Details | |
| 2023-05-04 07:54:02 -0500 | Rating Details | |
| 2023-05-04 17:48:06 -0500 | Rating Details | |
| 2023-05-04 11:16:58 -0500 | Rating Details | |
| 2023-05-04 08:39:18 -0500 | Rating Details | |
| 2023-05-04 08:49:52 -0500 | Rating Details | |
| 2023-05-03 22:43:41 -0500 | Rating Details | |
| 2023-05-04 00:08:19 -0500 | Rating Details | |
| 2023-05-03 21:21:48 -0500 | Rating Details | |
| 2023-05-04 18:57:47 -0500 | Rating Details | |
| 2023-05-03 19:49:26 -0500 | Rating Details | |
| 2023-05-04 02:51:54 -0500 | Rating Details | |
| 2023-05-04 08:17:14 -0500 | Rating Details | |
| 2023-05-04 18:26:55 -0500 | Rating Details | |
| 2023-05-03 22:39:07 -0500 | Rating Details | |
| 2023-05-04 10:30:02 -0500 | Rating Details | |
| 2023-05-04 06:51:27 -0500 | Rating Details | |
| 2023-05-04 21:45:40 -0500 | Rating Details | |
| 2023-05-04 07:24:08 -0500 | Rating Details | |
| 2023-05-04 07:41:05 -0500 | Rating Details | |
| 2023-05-03 18:57:23 -0500 | Rating Details | |
| 2023-05-06 15:50:40 -0500 | Rating Details | |
| 2023-05-04 06:53:06 -0500 | Rating Details | |
| 2023-05-03 19:11:03 -0500 | Rating Details | |
| 2023-05-04 09:42:11 -0500 | Rating Details | |
| 2023-05-04 11:00:26 -0500 | Rating Details | |
| 2023-05-04 00:19:42 -0500 | Rating Details | |
| 2023-05-04 13:22:10 -0500 | Rating Details | |
| 2023-05-03 18:44:58 -0500 | Rating Details | |
| 2023-05-04 01:26:33 -0500 | Rating Details | |
| 2023-05-03 20:49:35 -0500 | Rating Details | |
| 2023-05-04 18:07:46 -0500 | Rating Details | |
| 2023-05-04 11:51:37 -0500 | Rating Details | |
| 2023-05-05 15:58:24 -0500 | Rating Details | |
| 2023-05-04 18:46:58 -0500 | Rating Details | |
| 2023-05-05 13:20:00 -0500 | Rating Details | |
| 2023-05-04 07:24:57 -0500 | Rating Details | |
| 2023-05-04 07:50:59 -0500 | Rating Details | |
| 2023-05-04 07:00:37 -0500 | Rating Details | |
| 2023-05-03 20:44:18 -0500 | Rating Details | |
| 2023-05-04 09:48:21 -0500 | Rating Details | |
| 2023-05-03 19:57:47 -0500 | Rating Details | |
| 2023-05-03 22:41:37 -0500 | Rating Details | |
| 2023-05-04 07:24:15 -0500 | Rating Details | |
| 2023-05-04 20:40:07 -0500 | Rating Details | |
| 2023-05-03 22:06:27 -0500 | Rating Details | |
| 2023-05-03 19:52:32 -0500 | Rating Details | |
| 2023-05-03 20:32:53 -0500 | Rating Details | |
| 2023-05-08 20:45:50 -0500 | Rating Details | |
| 2023-05-03 18:23:35 -0500 | Rating Details | |
| 2023-05-04 20:34:18 -0500 | Rating Details | |
| 2023-05-04 07:30:56 -0500 | Rating Details | |
| 2023-05-04 07:25:58 -0500 | Rating Details | |
| 2023-05-04 05:16:03 -0500 | Rating Details | |
| 2023-05-03 20:31:41 -0500 | Rating Details | |
| 2023-05-03 19:02:52 -0500 | Rating Details | |
| 2023-05-04 07:52:54 -0500 | Rating Details | |
| 2023-05-04 20:26:32 -0500 | Rating Details | |
| 2023-05-03 20:06:05 -0500 | Rating Details | |
| 2023-05-03 22:11:12 -0500 | Rating Details | |
| 2023-05-04 07:11:59 -0500 | Rating Details | |
| 2023-05-05 11:37:54 -0500 | Rating Details | |
| 2023-05-04 07:00:49 -0500 | Rating Details | |
| 2023-05-03 21:40:53 -0500 | Rating Details | |
| 2023-05-04 07:30:21 -0500 | Rating Details | |
| 2023-05-04 06:23:19 -0500 | Rating Details | |
| 2023-05-04 05:37:04 -0500 | Rating Details | |
| 2023-05-04 08:11:29 -0500 | Rating Details | |
| 2023-05-04 07:37:29 -0500 | Rating Details | |
| 2023-05-04 07:40:22 -0500 | Rating Details | |
| 2023-05-03 20:14:23 -0500 | Rating Details | |
| 2023-05-04 15:12:33 -0500 | Rating Details | |
| 2023-05-05 09:06:58 -0500 | Rating Details | |
| 2023-05-03 20:50:34 -0500 | Rating Details | |
| 2024-01-17 11:51:05 -0600 | Rating Details |